ABL Texcell Diagnostics SA (EPA:ABLD)

ABL Texcell Diagnostics Revenue

In the year 2025, ABL Texcell Diagnostics had annual revenue of 6.95M EUR with 30.39% growth. ABL Texcell Diagnostics had revenue of 4.10M in the half year ending December 31, 2025, with 29.34% growth. That makes ABL Texcell Diagnostics the 36,294th largest company in the world by revenue and 469th in France.

• Revenue: 6.95M
• Revenue Growth: +30.39%
• P/S Ratio: 3.44
• Revenue / Employee: 445.14K
• Employees: 25
• Market Cap: 38.25M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Europe (Excluding France) 2.49M 35.8%
• France 2.10M 30.3%
• Other Areas 2.08M 30.0%
• United States of America 278.00K 4.0%

Fiscal year ended Dec 31, 2025 See the full ABL Texcell Diagnostics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.95M	1.62M	30.39%
Dec 31, 2024	5.33M	-282.46K	-5.03%
Dec 31, 2023	5.61M	-3.14M	-35.84%
Dec 31, 2022	8.75M	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	343.34K	-312.49K	-47.65%
Dec 31, 2017	655.83K	105.70K	19.21%
Dec 31, 2016	550.13K	228.03K	70.79%
Dec 31, 2015	322.10K	287.17K	822.05%
Dec 31, 2014	34.93K	24.14K	223.60%
Dec 31, 2013	10.80K	-1.87K	-14.73%
Dec 31, 2012	12.66K	-1.17K	-8.48%
Dec 31, 2011	13.83K	928.00	7.19%
Dec 31, 2010	12.91K	59.00	0.46%
Dec 31, 2009	12.85K	-2.90K	-18.43%
Dec 31, 2008	15.75K	1.13K	7.76%
Dec 31, 2007	14.61K	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: May 8, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Semi-annually

Last checked:

Oct 20, 2026

Data Sources Report a data error